Learn / IMNM
NASDAQ: IMNM
Immunome (IMNM) stock, explained like you're 5
Immunome trades on the Nasdaq under the ticker IMNM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
- Ticker
- IMNM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 2.3 billion dollars
Is Immunome a small, medium or large cap company?
No. Immunome is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Immunome makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IMNM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Immunome, Inc. (IMNM) stock price, news, quote and history (Yahoo Finance UK)
- Immunome Stock Gets A Boost In Visibility After William Blair Starts Outperform Coverage (Simply Wall Street)
- William Blair initiates Immunome stock coverage with outperform rating (Investing.com)
- Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
- IMNM Initiated Coverage by William Blair Rating Set to Outperform (GuruFocus)
Follow IMNM in your daily brief
Each trading day at 5 PM ET we post what happened to Immunome and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IMNM
Questions about Immunome stock
What does Immunome do?
Immunome trades on the Nasdaq under the ticker IMNM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
What is the ticker symbol for Immunome?
Immunome trades under the ticker IMNM on the Nasdaq.
What is Immunome's market cap?
Immunome is a mid cap stock with a market cap of about 2.3 billion dollars.
How does Immunome make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IMNM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IMNM stock every day?
Add IMNM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.